Jan 2026 ANVISA GMP renewed for Tarapur facility Read more

Newsroom

Naprod's Tarapur Facility Holds Active GMP Certification Across Six Global Agencies

Following the January 2026 ANVISA renewal, Naprod recaps its current register of confirmed international manufacturing certifications for the Tarapur site.

Following ANVISA’s renewal of GMP certification for the Tarapur site in January 2026, Naprod Life Sciences is recapping the current state of its international manufacturing accreditation register. Six agencies are confirmed and independently verifiable for the Tarapur facility: EU-GMP, WHO-GMP, ANVISA (Brazil), INVIMA (Colombia), the UAE Ministry of Health, and NHRA (Bahrain).

Each certification is issued, scoped, and renewed independently by its issuing authority and covers the manufacturing site’s quality systems and process controls rather than any individual product. A fuller register — including certifications still being digitized for publication — is maintained on the Quality & Regulatory section of this site, with scope, issuing body, and validity dates published as they are confirmed.